TrialObstetrics and gynecology2019

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

Sheryl A Kingsberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.